Correlation of Tc-diphosphonate bone scintigraphic findings and histologic grade in prostatic adenocinoma.
10.3348/jkrs.1993.29.6.1356
- Author:
So Jin LEE
;
Chang Yoon PARK
;
Jong Doo LEE
;
Jin Suck SUH
;
Jin Kyung HAHM
;
Nam Hoon CHO
- Publication Type:Original Article
- MeSH:
Adenocarcinoma;
Biopsy;
Diagnosis;
Methods;
Neoplasm Metastasis;
Radionuclide Imaging
- From:Journal of the Korean Radiological Society
1993;29(6):1356-1360
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Prostatic adenocarcinoma is a common genitourinary malignancy which frequently is assiciated with bony metastasis at initial diagnosis. The detection of bony metastasis is important because it often alters the therapeutic strategy. The radionuclide one scintigraphy is known to be the most sensitive diagnostic method in detecting bony metastasis from prostatic adenocarcinoma. In the histologic grading of prostatic adenocarcinoma, the Gleason's grading system is the most widely employed one which is based on the degree of glandular differentiation and the growth patterns of tumor in relation to the prostatic stroma. The purpose of this study is to know the correlation of Gleason's grade and bone scintigraphic findings in prostatic carcinoma. We analyzed 99mTc-diphosphonate bone scintigraphies of 19 cases with prostatic adenocarcinoma confirmed by transurethral prostatic biopsy. Ten of the 19 cases showed asymmetrical multiple radioisotope uptake suggesting bony metastases and their Gleason's grade were 4 or 5 in seven cases. The remaining three cases were Gleason's grade 2 or 3. Another nine cases showed symmetrical radioisotope uptake with normal renal imaging suggesting no bony metastases and their Gleason's grade were 1,2 or 3 in seven cases. The remaining two cases of these nine cases were Gleason's grade 4 and 5. As the results, there was a correlation between the Gleason's grade and bone scintigraphic findings. The asymmetrical multiple skeletal uptake of radioisotope may suggest that the Gleason's grade is likely to be higher.